12 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
effectiveness of business risk management processes. The Committee shall oversee an annual audit of the political contributions of the Company.
FSD
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
23 May 22
Annual General Meeting of the Shareholders
4:29pm
responsibilities and the overall effectiveness of business risk management processes. The Committee shall oversee an annual audit of the political
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
9 Dec 21
Regulatory Advisory Board will oversee the drug development pathway for FSD Pharma’s clinical drug candidates
8:00am
Regulatory Advisory Board will oversee the drug development pathway for FSD Pharma’s clinical drug candidates
TORONTO--(BUSINESS WIRE)--December 9
40-F
2020 FY
EX-99.1
QNTM
Quantum BioPharma Ltd
17 Mar 21
Annual report (Canada)
12:00am
conducted. Although we oversee the CMOs, we cannot control the manufacturing process of, and are completely dependent on, our CMO partners
40-F
EX-99.1
eymnvdso1 yfpp
4 Mar 20
Annual report (Canada)
12:29pm
40FR12B
EX-99.32
kro29hiro 7vubd5
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.9
lbigf2
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.39
zc0q9
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.28
lwpnoe7i3lold
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.36
8r4 tc0pv
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.47
eow7x
6 Dec 19
Initial registration of securities (Canada)
12:28pm
- Prev
- 1
- Next